253 related articles for article (PubMed ID: 21584646)
1. Systemic therapy options for unresectable and metastatic chordomas.
Stacchiotti S; Casali PG
Curr Oncol Rep; 2011 Aug; 13(4):323-30. PubMed ID: 21584646
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in understanding and managing chordomas: an update.
Connors SW; Aoun SG; Shi C; Peinado-Reyes V; Hall K; Bagley CA
F1000Res; 2020; 9():. PubMed ID: 32724558
[TBL] [Abstract][Full Text] [Related]
3. [Chordoma].
George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
[TBL] [Abstract][Full Text] [Related]
4. The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol.
Banu MA; Raza SM; Amini M; Seaman S; Rubino F; Snyder R; Patel S; DeMonte F; Conley AP
Neurosurg Focus; 2024 May; 56(5):E15. PubMed ID: 38691867
[TBL] [Abstract][Full Text] [Related]
5. [From bench to bedside for new treatment paradigms in chordomas: An update].
Méry B; Rowinski E; Guinand M; Benna M; Bousarsar A; Bosacki C; Vallard A; Magné N
Bull Cancer; 2020 Jan; 107(1):129-135. PubMed ID: 31882268
[TBL] [Abstract][Full Text] [Related]
6. Chordoma: the nonsarcoma primary bone tumor.
Chugh R; Tawbi H; Lucas DR; Biermann JS; Schuetze SM; Baker LH
Oncologist; 2007 Nov; 12(11):1344-50. PubMed ID: 18055855
[TBL] [Abstract][Full Text] [Related]
7. Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor.
Park L; Delaney TF; Liebsch NJ; Hornicek FJ; Goldberg S; Mankin H; Rosenberg AE; Rosenthal DI; Suit HD
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1514-21. PubMed ID: 16757128
[TBL] [Abstract][Full Text] [Related]
8. Chordoma: current concepts, management, and future directions.
Walcott BP; Nahed BV; Mohyeldin A; Coumans JV; Kahle KT; Ferreira MJ
Lancet Oncol; 2012 Feb; 13(2):e69-76. PubMed ID: 22300861
[TBL] [Abstract][Full Text] [Related]
9. Novel therapeutic targets in chordoma.
Bydon M; Papadimitriou K; Witham T; Wolinsky JP; Bydon A; Sciubba D; Gokaslan Z
Expert Opin Ther Targets; 2012 Nov; 16(11):1139-43. PubMed ID: 22860993
[TBL] [Abstract][Full Text] [Related]
10. Current therapeutic options and novel molecular markers in skull base chordomas.
Gagliardi F; Boari N; Riva P; Mortini P
Neurosurg Rev; 2012 Jan; 35(1):1-13; discussion 13-4. PubMed ID: 22006091
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse.
Fagundes MA; Hug EB; Liebsch NJ; Daly W; Efird J; Munzenrider JE
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):579-84. PubMed ID: 7558946
[TBL] [Abstract][Full Text] [Related]
12. [Particle beam radiotherapy with a surgical spacer placement for unresectable sacral chordoma].
Takahashi M; Fukumoto T; Kusunoki N; Tsuchida S; Kido M; Takebe A; Awazu M; Kataoka Y; Matsumoto I; Miki T; Hori Y; Suzuki S; Kuroda D; Murakami M; Hishikawa Y; Ku Y
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2804-6. PubMed ID: 21224719
[TBL] [Abstract][Full Text] [Related]
13. Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study.
Nikoghosyan AV; Karapanagiotou-Schenkel I; Münter MW; Jensen AD; Combs SE; Debus J
BMC Cancer; 2010 Nov; 10():607. PubMed ID: 21054824
[TBL] [Abstract][Full Text] [Related]
14. Medical treatment of advanced chordomas.
Colia V; Stacchiotti S
Eur J Cancer; 2017 Sep; 83():220-228. PubMed ID: 28750274
[TBL] [Abstract][Full Text] [Related]
15. Chordoma dedifferentiation after proton beam therapy: a case report and review of the literature.
Frankl J; Grotepas C; Stea B; Lemole GM; Chiu A; Khan R
J Med Case Rep; 2016 Oct; 10(1):280. PubMed ID: 27729085
[TBL] [Abstract][Full Text] [Related]
16. Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases.
Fleming GF; Heimann PS; Stephens JK; Simon MA; Ferguson MK; Benjamin RS; Samuels BL
Cancer; 1993 Aug; 72(3):714-8. PubMed ID: 8334623
[TBL] [Abstract][Full Text] [Related]
17. Multimodality Management of Recurrent Skull Base Chordomas: Factors Impacting Tumor Control and Disease-Specific Survival.
Raza SM; Bell D; Freeman JL; Grosshans DR; Fuller GN; DeMonte F
Oper Neurosurg (Hagerstown); 2018 Aug; 15(2):131-143. PubMed ID: 29040778
[TBL] [Abstract][Full Text] [Related]
18. The biological basis for modern treatment of chordoma.
Diaz RJ; Cusimano MD
J Neurooncol; 2011 Sep; 104(2):411-22. PubMed ID: 21384217
[TBL] [Abstract][Full Text] [Related]
19. Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy.
Takahashi S; Kawase T; Yoshida K; Hasegawa A; Mizoe JE
Acta Neurochir (Wien); 2009 Jul; 151(7):759-69. PubMed ID: 19434365
[TBL] [Abstract][Full Text] [Related]
20. Multidisciplinary management of recurrent chordomas.
Yamada Y; Gounder M; Laufer I
Curr Treat Options Oncol; 2013 Sep; 14(3):442-53. PubMed ID: 23860859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
